NR565 Advanced Pharmacology Midterm Exam Structured
Question Bank (Latest 2026/2027 Edition) – Questions,
Answers & Detailed Rationales
──────────────────────────────
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Q1–Q8)
──────────────────────────────
Question 1
Which pharmacokinetic parameter represents the ratio of the toxic dose to the effective
dose in 50% of the population and serves as a primary indicator of drug safety?
A. Bioavailability
B. Therapeutic index ✓
C. Volume of distribution
D. Clearance
Correct Answer: B
Rationale:
The therapeutic index (TD50/ED50) quantifies the margin of safety between effective
and toxic doses. A low therapeutic index (<5) indicates a narrow safety margin requiring
careful monitoring and often therapeutic drug monitoring, while a high therapeutic index
indicates a wide safety margin.
Question 2
A nurse practitioner initiates warfarin therapy in a 70-year-old patient with atrial
fibrillation. Approximately how many days are required to achieve steady-state plasma
concentrations?
A. 1 to 2 days
B. 3 to 4 days
C. 5 to 7 days ✓
,D. 10 to 14 days
Correct Answer: C
Rationale:
Steady-state plasma concentrations are typically achieved after 4 to 5 half-lives.
Warfarin has a half-life of approximately 20 to 60 hours (mean 40 hours), requiring 5 to
7 days to reach steady state. INR monitoring should be frequent during this initiation
period.
Question 3
A patient with Child-Pugh Class B cirrhosis is prescribed a medication that undergoes
extensive first-pass metabolism. Which pharmacokinetic change is most likely to occur?
A. Increased bioavailability due to reduced hepatic extraction ✓
B. Decreased half-life due to enhanced hepatic clearance
C. Increased renal clearance compensating for hepatic dysfunction
D. Decreased volume of distribution due to ascites
Correct Answer: A
Rationale:
In hepatic cirrhosis, reduced hepatic blood flow and hepatocellular dysfunction
decrease first-pass metabolism, resulting in increased bioavailability of drugs with high
extraction ratios. This necessitates dose reductions for high first-pass drugs such as
propranolol, morphine, and many statins.
Question 4
A 45-year-old patient requires intravenous digoxin loading for atrial fibrillation with rapid
ventricular response. The desired plasma concentration is 1.5 mcg/L and the volume of
distribution is 500 L. What is the appropriate loading dose?
A. 0.25 mg
B. 0.5 mg
, C. 0.75 mg ✓
D. 1.0 mg
Correct Answer: C
Rationale:
Loading dose = Target concentration × Volume of distribution. 1.5 mcg/L × 500 L = 750
mcg = 0.75 mg. This calculation ensures rapid achievement of therapeutic
concentrations without excessive toxicity in a patient with normal renal function.
Question 5
A patient with hypertension is prescribed a non-selective beta-blocker. Which
pharmacodynamic principle explains the drug's mechanism of action?
A. Partial agonist activity at beta-adrenergic receptors
B. Competitive antagonism at beta-1 and beta-2 adrenergic receptors ✓
C. Irreversible inhibition of angiotensin-converting enzyme
D. Allosteric modulation of calcium channels
Correct Answer: B
Rationale:
Non-selective beta-blockers such as propranolol and nadolol act as competitive
antagonists at both beta-1 (cardiac) and beta-2 (pulmonary/vascular) adrenergic
receptors, reducing heart rate, contractility, and renin release without intrinsic
sympathomimetic activity.
Question 6
A 72-year-old male weighing 70 kg with a serum creatinine of 1.2 mg/dL is prescribed
gentamicin for a complicated urinary tract infection. Using the Cockcroft-Gault equation,
what is his estimated creatinine clearance?
A. 45 mL/min
B. 55 mL/min ✓
Question Bank (Latest 2026/2027 Edition) – Questions,
Answers & Detailed Rationales
──────────────────────────────
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Q1–Q8)
──────────────────────────────
Question 1
Which pharmacokinetic parameter represents the ratio of the toxic dose to the effective
dose in 50% of the population and serves as a primary indicator of drug safety?
A. Bioavailability
B. Therapeutic index ✓
C. Volume of distribution
D. Clearance
Correct Answer: B
Rationale:
The therapeutic index (TD50/ED50) quantifies the margin of safety between effective
and toxic doses. A low therapeutic index (<5) indicates a narrow safety margin requiring
careful monitoring and often therapeutic drug monitoring, while a high therapeutic index
indicates a wide safety margin.
Question 2
A nurse practitioner initiates warfarin therapy in a 70-year-old patient with atrial
fibrillation. Approximately how many days are required to achieve steady-state plasma
concentrations?
A. 1 to 2 days
B. 3 to 4 days
C. 5 to 7 days ✓
,D. 10 to 14 days
Correct Answer: C
Rationale:
Steady-state plasma concentrations are typically achieved after 4 to 5 half-lives.
Warfarin has a half-life of approximately 20 to 60 hours (mean 40 hours), requiring 5 to
7 days to reach steady state. INR monitoring should be frequent during this initiation
period.
Question 3
A patient with Child-Pugh Class B cirrhosis is prescribed a medication that undergoes
extensive first-pass metabolism. Which pharmacokinetic change is most likely to occur?
A. Increased bioavailability due to reduced hepatic extraction ✓
B. Decreased half-life due to enhanced hepatic clearance
C. Increased renal clearance compensating for hepatic dysfunction
D. Decreased volume of distribution due to ascites
Correct Answer: A
Rationale:
In hepatic cirrhosis, reduced hepatic blood flow and hepatocellular dysfunction
decrease first-pass metabolism, resulting in increased bioavailability of drugs with high
extraction ratios. This necessitates dose reductions for high first-pass drugs such as
propranolol, morphine, and many statins.
Question 4
A 45-year-old patient requires intravenous digoxin loading for atrial fibrillation with rapid
ventricular response. The desired plasma concentration is 1.5 mcg/L and the volume of
distribution is 500 L. What is the appropriate loading dose?
A. 0.25 mg
B. 0.5 mg
, C. 0.75 mg ✓
D. 1.0 mg
Correct Answer: C
Rationale:
Loading dose = Target concentration × Volume of distribution. 1.5 mcg/L × 500 L = 750
mcg = 0.75 mg. This calculation ensures rapid achievement of therapeutic
concentrations without excessive toxicity in a patient with normal renal function.
Question 5
A patient with hypertension is prescribed a non-selective beta-blocker. Which
pharmacodynamic principle explains the drug's mechanism of action?
A. Partial agonist activity at beta-adrenergic receptors
B. Competitive antagonism at beta-1 and beta-2 adrenergic receptors ✓
C. Irreversible inhibition of angiotensin-converting enzyme
D. Allosteric modulation of calcium channels
Correct Answer: B
Rationale:
Non-selective beta-blockers such as propranolol and nadolol act as competitive
antagonists at both beta-1 (cardiac) and beta-2 (pulmonary/vascular) adrenergic
receptors, reducing heart rate, contractility, and renin release without intrinsic
sympathomimetic activity.
Question 6
A 72-year-old male weighing 70 kg with a serum creatinine of 1.2 mg/dL is prescribed
gentamicin for a complicated urinary tract infection. Using the Cockcroft-Gault equation,
what is his estimated creatinine clearance?
A. 45 mL/min
B. 55 mL/min ✓
